Co-Diagnostics, Inc. cotiza a 1.25 USD y tiene una capitalización bursátil de $9M. En los últimos 12 meses ha facturado $721387 con un margen de flujo de caja libre del -4793.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction tes…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-4.09 | $-4.44 | $-4.66 |
| Estimado | $-3.00 | $-3.75 | $-3.60 | $-5.70 |
| Sorpresa | — | -9.1% | -23.3% | +18.2% |
| Métrica | CODX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 64.3% | 57.0% | +7.2% |
| Operating Margin | -8058.8% | -38.6% | -8020.2% |
| Net Margin | -7533.6% | -33.6% | -7500.1% |
| FCF Margin | -4793.2% | -13.9% | -4779.3% |
| ROE | -227.3% | -40.4% | -186.9% |
| ROA | -189.5% | -32.0% | -157.5% |
| Current Ratio | 3.87 | 2.84 | +1.03 |
| Debt / Equity | — | 0.28 | — |